BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 8370583)

  • 41. [Births: developments in the past and expectations for the future].
    Vermunt JK
    Maandstat Bevolking; 1992 Jan; 40(1):18-28. PubMed ID: 12317136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trends in Down's syndrome prevalence in California, 1983-1988.
    Hahn JA; Shaw GM
    Paediatr Perinat Epidemiol; 1993 Oct; 7(4):450-60. PubMed ID: 8290384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Attitudes of women of childbearing age towards prenatal diagnosis in southeastern France.
    Julian-Reynier C; Macquart-Moulin G; Moatti JP; Loundou A; Aurran Y; Chabal F; Aymé S
    Prenat Diagn; 1993 Jul; 13(7):613-27. PubMed ID: 8415427
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of a regional screening programme using maternal serum alpha fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland.
    Crossley JA; Aitken DA; Berry E; Connor JM
    J Med Screen; 1994 Jul; 1(3):180-3. PubMed ID: 8790513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Birth history, age structure, and post World War II fertility in ten developed countries: an exploratory empirical analysis.
    Artzrouni MA; Easterlin RA
    Genus; 1982; 38(3-4):81-99. PubMed ID: 12312903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prenatal diagnosis, pregnancy terminations and prevalence of Down syndrome in Atlanta.
    Siffel C; Correa A; Cragan J; Alverson CJ
    Birth Defects Res A Clin Mol Teratol; 2004 Sep; 70(9):565-71. PubMed ID: 15368554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of prenatal screening and diagnostic testing on trends in Down syndrome births and terminations in Western Australia 1980 to 2013.
    Maxwell S; Bower C; O'Leary P
    Prenat Diagn; 2015 Dec; 35(13):1324-30. PubMed ID: 26411476
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prevalence of selected congenital anomalies in the Czech Republic: renal and cardiac anomalies and congenital chromosomal aberrations].
    Šípek A; Gregor V; Horáček J; Šípek A; Langhammer P
    Epidemiol Mikrobiol Imunol; 2013 Sep; 62(3):112-28. PubMed ID: 24116699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trisomies 18 and 13: trends in prevalence and prenatal diagnosis - population based study.
    Tonks AM; Gornall AS; Larkins SA; Gardosi JO
    Prenat Diagn; 2013 Aug; 33(8):742-50. PubMed ID: 23553654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of the number of Down's syndrome infants to be born in England and Wales up to the year 2000 and their likely survival rates.
    Nicholson A; Alberman E
    J Intellect Disabil Res; 1992 Dec; 36 ( Pt 6)():505-17. PubMed ID: 1477488
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Teenage pregnancy in Scotland: trends and risks.
    Rosenberg K; McEwan HP
    Scott Med J; 1991 Dec; 36(6):172-4. PubMed ID: 1805377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of neural tube defects in South Australia, 1966-91: effectiveness and impact of prenatal diagnosis.
    Chan A; Robertson EF; Haan EA; Keane RJ; Ranieri E; Carney A
    BMJ; 1993 Sep; 307(6906):703-6. PubMed ID: 8401091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eastern Europe: pronatalist policies and private behavior.
    David HP
    Popul Bull; 1982 Feb; 36(6):1-49. PubMed ID: 12338315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Epidemiology of prenatal diagnosis and selective pregnancy termination because of fetal neural tube defects in The Netherlands in comparison to other European countries].
    Cornel MC; Leurquin P; de Walle HE; Staal-Schreinemachers AL; Beekhuis JR
    Ned Tijdschr Geneeskd; 1997 Nov; 141(46):2239-44. PubMed ID: 9550786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. National screening guidelines and developments in prenatal diagnoses and live births of Down syndrome in 1973-2016 in Denmark.
    Lou S; Petersen OB; Jørgensen FS; Lund ICB; Kjaergaard S; ; Vogel I
    Acta Obstet Gynecol Scand; 2018 Feb; 97(2):195-203. PubMed ID: 29194566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prenatal genetic diagnosis and elective abortion in women over 35: utilization and relative impact on the birth prevalence of Down syndrome in Washington State.
    Luthy DA; Emanuel I; Hoehn H; Hall JG; Powers EK
    Am J Med Genet; 1980; 7(3):375-81. PubMed ID: 6451173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Population-based trends in prenatal screening and diagnosis for aneuploidy: a retrospective analysis of 38 years of state-wide data.
    Hui L; Muggli EE; Halliday JL
    BJOG; 2016 Jan; 123(1):90-7. PubMed ID: 26108969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current French practices for prenatal diagnosis of trisomy 21: a population-based study in Paris, 1992-97.
    De Vigan C; Vodovar V; Vérité V; Dehé S; Goujard J
    Prenat Diagn; 1999 Dec; 19(12):1113-8. PubMed ID: 10590427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advances in prenatal screening for Down syndrome: I. general principles and second trimester testing.
    Benn PA
    Clin Chim Acta; 2002 Sep; 323(1-2):1-16. PubMed ID: 12135803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Results of first year (1989) of a national register of Down's syndrome in England and Wales.
    Mutton DE; Alberman E; Ide R; Bobrow M
    BMJ; 1991 Nov; 303(6813):1295-7. PubMed ID: 1836152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.